Delivery Order SPE2DB20D1050-SPE2DB25FH89E
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,017.78 by the Defense Logistics Agency on July 18, 2025, with an ultimate completion date of July 21, 2025. The delivery order, issued under a firm fixed-price contract type with no set-aside designation, covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in treating chronic obstructive pulmonary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication used to treat chronic obstructive pulmonary disease. This competitive, non-set-aside contract was awarded on July 30, 2025, with a ceiling value of $1,383.71 and an ultimate completion date of July 31, 2025. The delivery order will be performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $23,940.27 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, with an ultimate completion date of August 28, 2025. The delivery order, issued without set-aside designation through competitive procedures, covers TRELEGY ELLIPTA 200-62.5-25 (a combination inhalation medication for chronic obstructive pulmonary disease) in a 60-unit...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $98,086.77 for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $13,390.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination pharmaceutical product used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,679.80 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- AmerisourceBergen Drug Corp received a delivery order contract valued at $37,479.45 from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. The contract was completed on August 22, 2025, with performance...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH89EDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for TRELEGY ELLIPTA 100-62.5-25 (60 count) by the Defense Logistics Agency on September 8, 2025. The award carries a ceiling value of $1,441.50 and represents a firm fixed price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. This child contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The Defense Logistics Agency, operating under the Department of Defense, utilizes this prime vendor contract to supply critical pharmaceutical products to military and veteran healthcare systems. TRELEGY ELLIPTA is a combination respiratory medication prescribed for chronic obstructive pulmonary disease management. As a major pharmaceutical distributor with extensive federal contracting experience, AmerisourceBergen maintains the capability to fulfill diverse medical supply requirements across multiple therapeutic domains through open competition. The delivery order is scheduled for completion by September 9, 2025, with performance based at the company's corporate office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/8/25 |